| # | Drug | Count |
|---|---|---|
| 0 | TEDUGLUTIDE | 18 |
| 1 | ACETAMINOPHEN | 14 |
| 2 | ACETAMINOPHEN 500MG | 14 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 14 |
| 4 | CODEINE SULFATE | 14 |
| 5 | DIMENHYDRINATE | 14 |
| 6 | MAGNESIUM | 14 |
| 7 | PAIN RELIEVER | 14 |
| 8 | ASPIRIN | 13 |
| 9 | ASPIRIN 325 MG | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHROMIC CHLORIDE | 11 | 0.0128 |
| 1 | HYALURONATE SODIUM | 12 | 0.0078 |
| 2 | POTASSIUM IODIDE | 11 | 0.0074 |
| 3 | EFINACONAZOLE | 13 | 0.0066 |
| 4 | CODEINE SULFATE | 14 | 0.0042 |
| 5 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 2 | 0.0042 |
| 6 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 5 | 0.0026 |
| 7 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE | 5 | 0.0026 |
| 8 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 11 | 0.0018 |
| 9 | MAGNESIUM CITRATE ORAL SOLUTION | 11 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-2 Analog [EPC] | 18 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 2 | Azole Antifungal [EPC] | 14 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 4 | Loop Diuretic [EPC] | 12 |
| 5 | Calcium [EPC] | 6 |
| 6 | Nonergot Dopamine Agonist [EPC] | 6 |
| 7 | Provitamin D2 Compound [EPC] | 6 |
| 8 | Atypical Antipsychotic [EPC] | 5 |
| 9 | Platinum-based Drug [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 18 | 0.0013 |
| 1 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 2 | Nonergot Dopamine Agonist [EPC] | 6 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 4 | Azole Antifungal [EPC] | 14 | 0.0001 |
| 5 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Calcium [EPC] | 6 | 0.0000 |
| 8 | Aromatic Amino Acid [EPC] | 2 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |